Shares in Eli Lilly rise as Zepbound weight-loss study shows solid success
Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug maker also said more…
Regulator acts to close loophole enabling Australian pharmacists to make copycat Ozempic drug
In short: The family of drugs used to make Ozempic and Mounjaro will be removed from Australia's compounding exemptions, stopping pharmacies from making off-brand replicas.Compounding…